Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeles Alvarez Secord

Showing results (31-40 of 239) with videos related to

Pageof 24
Sort By:
Gynecologic Oncology Case Reports|December 28, 2013
Recurrent granulosa cell tumor presenting with spontaneous retroperitoneal hemorrhage: A case reportSabino Zani, Maggie Stoecker, Mitchell W Cox, et al.
Gynecologic Oncology|May 29, 2012
Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group StudyCarol Aghajanian, Michael W Sill, Angeles Alvarez Secord, et al.
Gynecologic Oncology Case Reports|December 28, 2013
Metastatic adenocarcinoma after laparoscopic supracervical hysterectomy with morcellation: A case reportTaylor Turner, Angeles Alvarez Secord, William J Lowery, et al.
Gynecologic Oncology Research and Practice|May 28, 2016
Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigmsLauren Patterson Cobb, Stephanie Gaillard, Yihong Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group studyLaura J Havrilesky, Angeles Alvarez Secord, Kathleen M Darcy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 8, 2025
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcomaMichael Toboni, Katherine Kurnit, Britt Erickson, et al.
Gynecologic Oncology|July 21, 2004
The role of optimal debulking in advanced stage serous carcinoma of the uterusKaren A Moller, Paola A Gehrig, Linda Van Le, et al.
Gynecologic Oncology|September 29, 2007
Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysisElizabeth L Jewell, Shalini Kulasingam, Evan R Myers, et al.
Gynecologic Oncology|May 3, 2005
Rectus abdominis myocutaneous and myoperitoneal flaps for neovaginal reconstruction after radical pelvic surgery: comparison of flap-related morbidityJohn T Soper, Angeles Alvarez Secord, Laura J Havrilesky, et al.
Gynecologic Oncology|June 6, 2021
Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A reviewAngeles Alvarez Secord, David M O'Malley, Anil K Sood, et al.
Pageof 24

Showing results (31-40 of 239) with videos related to

Sort By:
Pageof 24
Gynecologic Oncology Case Reports|December 28, 2013
Recurrent granulosa cell tumor presenting with spontaneous retroperitoneal hemorrhage: A case reportSabino Zani, Maggie Stoecker, Mitchell W Cox, et al.
Gynecologic Oncology|May 29, 2012
Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group StudyCarol Aghajanian, Michael W Sill, Angeles Alvarez Secord, et al.
Gynecologic Oncology Case Reports|December 28, 2013
Metastatic adenocarcinoma after laparoscopic supracervical hysterectomy with morcellation: A case reportTaylor Turner, Angeles Alvarez Secord, William J Lowery, et al.
Gynecologic Oncology Research and Practice|May 28, 2016
Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigmsLauren Patterson Cobb, Stephanie Gaillard, Yihong Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group studyLaura J Havrilesky, Angeles Alvarez Secord, Kathleen M Darcy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 8, 2025
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcomaMichael Toboni, Katherine Kurnit, Britt Erickson, et al.
Gynecologic Oncology|July 21, 2004
The role of optimal debulking in advanced stage serous carcinoma of the uterusKaren A Moller, Paola A Gehrig, Linda Van Le, et al.
Gynecologic Oncology|September 29, 2007
Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysisElizabeth L Jewell, Shalini Kulasingam, Evan R Myers, et al.
Gynecologic Oncology|May 3, 2005
Rectus abdominis myocutaneous and myoperitoneal flaps for neovaginal reconstruction after radical pelvic surgery: comparison of flap-related morbidityJohn T Soper, Angeles Alvarez Secord, Laura J Havrilesky, et al.
Gynecologic Oncology|June 6, 2021
Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A reviewAngeles Alvarez Secord, David M O'Malley, Anil K Sood, et al.
Pageof 24